Neurocutaneous syndromes pediatric research and clinical trials

The Boston Children's Hospital Neurofibromatosis Program has recently been chosen by the Department of Defense to form a clinical trials consortium with eight other neurofibromatosis centers in the United States.

This group of centers will join together to develop and implement clinical trials in NF1 for treatment of complications of this condition, including neurofibomas, optic gliomas, and learning disabilities.